Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Elysium Health Announces the Launch of Creatine+, a First-of-Its-Kind Longevity-Focused Creatine System Designed to Support Strength, Recovery, and Cognition

Working with the world's leading scientists and clinicians, Elysium Health's™ mission is to to improve human healthspan and lifespan by providing direct access to breakthroughs in longevity science. Learn more at elysiumhealth.com.

News provided by

Elysium Health

Jun 15, 2026, 08:35 ET

Share this article

Share toX

Share this article

Share toX

Developed with the advisement of Michael Fredericson, M.D., Co-Director of the Stanford Center on Longevity, Creatine+ uniquely combines creatine monohydrate with HMB and pomegranate polyphenols

NEW YORK, June 15, 2026 /PRNewswire/ -- Elysium Health, Inc.™, the leading longevity science company, today announced the launch of CREATINE+™ by Elysium Health, a novel 3-in-1 creatine system formulated specifically for longevity that supports strength, recovery, and cognition. Developed with the advisement of Michael Fredericson, M.D., Co-Director of the Stanford Center on Longevity, Professor and Director of PM&R Sports Medicine at Stanford University, and Elysium Scientific Advisory Board member, Creatine+ uniquely combines three scientifically validated ingredients—creatine monohydrate, HMB (β-hydroxy β-methylbutyrate), and pomegranate polyphenols standardized to urolithin A precursors—to address multiple biological pathways involved in overall long-term health, including age-related muscle decline, physical function, and cognition.

Continue Reading
Based on 10 g creatine or 10 g creatine + 3 g HMB daily for 2 weeks, combined with resistance training (after 1-week loading phase). Adapted from Jówko et al., Nutrition. 2001.
Based on 10 g creatine or 10 g creatine + 3 g HMB daily for 2 weeks, combined with resistance training (after 1-week loading phase). Adapted from Jówko et al., Nutrition. 2001.
CREATINE+ is a novel 3-in-1 system formulated specifically for longevity that supports strength, recovery, and cognition. Developed with the advisement of Dr. Michael Fredericson, Co-Director of the Stanford Center on Longevity, Creatine+ uniquely combines three scientifically validated ingredients—creatine monohydrate, HMB, and urolithin A precursors—to address multiple biological pathways involved in long-term health, including age-related muscle decline, physical function, and cognition.
CREATINE+ is a novel 3-in-1 system formulated specifically for longevity that supports strength, recovery, and cognition. Developed with the advisement of Dr. Michael Fredericson, Co-Director of the Stanford Center on Longevity, Creatine+ uniquely combines three scientifically validated ingredients—creatine monohydrate, HMB, and urolithin A precursors—to address multiple biological pathways involved in long-term health, including age-related muscle decline, physical function, and cognition.

While creatine has long been recognized as one of the most studied and effective supplements for supporting muscle performance, it has recently gained widespread attention beyond athletes and fitness enthusiasts as research increasingly highlights the importance of muscle health for healthy aging, mobility, and longevity. By age 80, muscle mass decreases by approximately 30%, strength by 40%, and power by 50%. Creatine+ was designed to help address this challenge by uniquely combining ingredients that support muscle energetics, recovery, mitochondrial health, and cognition—the biological foundations of longevity and strength.

Creatine+ features a comprehensive formulation designed specifically for longevity, not just athletic performance:

  • The highest purity micronized creatine monohydrate to support lean muscle, strength, and cognition
  • HMB, which works synergistically with creatine to support recovery and build muscle, as well as prevent muscle loss—meaning you keep more of the muscle you gain
  • Pomegranate polyphenols standardized to urolithin A precursors to support mitochondrial renewal and cellular energy production

"Creatine has become one of my favorite supplements for supporting the maintenance of lean body mass, strength, and performance as we age, especially when paired with consistent resistance training," said Dr. Fredericson, Co-Director of the Stanford Center on Longevity and Elysium Scientific Advisory Board member. "What's unique about Creatine+ is that it optimizes for two critical components of athletic performance—both output and recovery. I highly recommend creatine for men and women, but women especially face distinct changes in muscle physiology, and Creatine+ offers targeted nutritional support for maintaining performance and vitality."

Maintaining muscle health, mobility, and quality of life as we age requires more than simply building muscle. Creatine+ was designed to address multiple aspects of longevity by combining the highest-purity creatine monohydrate, micronized for superior solubility and bioavailability, with HMB—which supports recovery, helps reduce exercise-related muscle damage, and helps you maintain more of the muscle you build—and pomegranate polyphenols standardized to urolithin A precursors, which support mitochondrial health and cellular energy production. Clinical studies have shown that combining creatine with HMB can produce greater gains in lean muscle mass and strength than creatine alone. By pairing these ingredients with pomegranate-derived polyphenols that promote mitochondrial renewal, Creatine+ delivers a more comprehensive approach to supporting strength, recovery, cognition, and long-term muscle vitality.

"Over the last several years, creatine has evolved from a supplement primarily associated with athletes and gym-goers into one of the most widely popular interventions for healthy aging," said Elysium CEO Eric Marcotulli. "That shift reflects a growing recognition that muscle health is one of the most important predictors of long-term health, independence, and quality of life. At Elysium, we have always focused on translating advances in longevity science into products that help people not just age better but live better. Creatine+ is a natural extension of that mission—a scientifically rigorous formulation designed to support strength today, and to help preserve physical function, resilience, and cognition over the long term."

Creatine+ is available now at elysiumhealth.com.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

About Elysium Health™

Elysium Health's™ mission is to solve the biggest challenges in health with science, to help people lead healthier lives. Working directly with the world's leading scientists and clinicians, Elysium Health™ is committed to translating critical advancements in aging research into health solutions people can access today. Elysium Health™ is backed by General Catalyst, Morningside Ventures, Breyer Capital, Mayo Clinic Ventures, and other notable investors. Learn more at elysiumhealth.com.

SOURCE Elysium Health

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Elysium Health™ Announces the Launch of The Elysium Longevity Institute™ (TELI)

Elysium Health™ Announces the Launch of The Elysium Longevity Institute™ (TELI)

Elysium Health, Inc.™, the leading longevity science company, today announced the launch of The Elysium Longevity Institute™ (TELI), a science-first, ...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Supplementary Medicine

Supplementary Medicine

Fitness/Wellness

Fitness/Wellness

New Products & Services

New Products & Services

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.